-
Somite Therapeutics Announces FDA Orphan Drug and Rare Pediatric Disease Designations for SMT-M01 in Duchenne Muscular Dystrophy | Morningstar
Source: Buzz FX / 16 Sep 2024 09:31:14 America/New_York
[PR Newswire](/news/pr-newswire) Somite Therapeutics Announces FDA Orphan Drug and Rare Pediatric Disease Designations for SMT-M01 in Duchenne Muscular Dystrophy Somite Therapeutics Announces FDA Orphan Drug and Rare Pediatric Disease Desig
Read more...